Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2012-12-17 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-THEGONNEC LOC-EGUINER (29410), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE SAINT THEGONNEC : revenue, balance sheet and financial ratios
PHARMACIE DE SAINT THEGONNEC is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-THEGONNEC LOC-EGUINER (29410),
this company of category PME
shows in 2024 a net income positive of 80 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SAINT THEGONNEC (SIREN 790041347)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
80 091 €
49 575 €
83 079 €
67 137 €
85 522 €
108 503 €
142 053 €
123 248 €
96 964 €
144 801 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE SAINT THEGONNEC generates positive net income of 80 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 145 k€ -> 80 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
80 091 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 100%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
99.678%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.093%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SAINT THEGONNEC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
230.35
51.049
44.346
37.837
223.983
189.389
164.523
138.822
121.056
99.678
Financial autonomy
26.765
60.696
62.728
67.674
28.473
32.137
33.697
37.199
40.332
42.093
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
99.682024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE DE SAINT THEGONNEC (99.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.09%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DE SAINT THEGONNEC (42.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 134.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
134.416
Liquidity indicators evolution PHARMACIE DE SAINT THEGONNEC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
215.674
236.426
228.935
316.546
296.414
314.586
217.376
203.158
171.013
134.416
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
134.422024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-24 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE SAINT THEGONNEC (134.42) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DE SAINT THEGONNEC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE SAINT THEGONNEC is estimated at
1 118 129 €
(range 778 647€ - 1 672 785€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
778k€1118k€1672k€
1 118 129 €Range: 778 647€ - 1 672 785€
NAF 5 année 2024
Valuation method used
Net Income Multiple
80 091 €
×
14.0x
=1 118 130 €
Range: 778 648€ - 1 672 786€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SAINT THEGONNEC with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SAINT THEGONNEC
What is the revenue of PHARMACIE DE SAINT THEGONNEC ?
The revenue of PHARMACIE DE SAINT THEGONNEC is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE SAINT THEGONNEC profitable?
Yes, PHARMACIE DE SAINT THEGONNEC generated a net profit of 80 k€ in 2024.
Where is the headquarters of PHARMACIE DE SAINT THEGONNEC ?
The headquarters of PHARMACIE DE SAINT THEGONNEC is located in SAINT-THEGONNEC LOC-EGUINER (29410), in the department Finistere.
Where to find the tax return of PHARMACIE DE SAINT THEGONNEC ?
The tax return of PHARMACIE DE SAINT THEGONNEC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SAINT THEGONNEC operate?
PHARMACIE DE SAINT THEGONNEC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart